We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current ANIX market cap is 84.53M. The company's latest EPS is USD -0.3076 and P/E is -8.58.
| Quarter End | Jan 2023 | Apr 2023 | Jul 2023 | Oct 2023 | Jan 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 210k | 0 | 0 | 0 |
| Operating Income | -2.56M | -2.56M | -2.84M | -3.05M | -3.61M |
| Net Income | -2.32M | -2.29M | -2.51M | -2.69M | -3.26M |
| Year End October 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 250k | 0 | 513k | 0 | 210k |
| Operating Income | -11.89M | -9.98M | -13.14M | -13.88M | -11.01M |
| Net Income | -11.65M | -10.02M | -12.95M | -13.6M | -9.81M |
| Quarter End | Jan 2023 | Apr 2023 | Jul 2023 | Oct 2023 | Jan 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 28.31M | 27.6M | 26.58M | 25.52M | 25.37M |
| Total Liabilities | 1.39M | 1.69M | 1.99M | 2.15M | 1.77M |
| Total Equity | 26.91M | 25.91M | 24.59M | 23.37M | 23.6M |
| Year End October 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 6.29M | 9.45M | 36.26M | 30.41M | 25.52M |
| Total Liabilities | 1.48M | 1.19M | 1.49M | 2.21M | 2.15M |
| Total Equity | 4.81M | 8.26M | 34.77M | 28.2M | 23.37M |
| Quarter End | Jan 2023 | Apr 2023 | Jul 2023 | Oct 2023 | Jan 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -1.99M | -2.8M | -4.24M | -6.21M | -2.31M |
| Investing | -585k | -4.03M | -5.01M | -5.6M | 129k |
| Financing | 3k | 84k | 87k | 366k | 2.26M |
| Year End October 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -4.74M | -6.18M | -4.94M | -6.49M | -6.21M |
| Investing | -525k | -306k | -3.92M | -10.73M | -5.6M |
| Financing | 5.7M | 9.41M | 31.57M | 452k | 366k |
| Market Cap | 84.53M |
| Price to Earnings Ratio | -8.58 |
| Price to Sales Ratio | 400 |
| Price to Cash Ratio | 91.99 |
| Price to Book Ratio | 3.6 |
| Dividend Yield | - |
| Shares Outstanding | 31.9M |
| Average Volume (1 week) | 108.9k |
| Average Volume (1 Month) | 92.49k |
| 52 Week Change | -16.67% |
| 52 Week High | 5.13 |
| 52 Week Low | 2.21 |
| Spread (Intraday) | 0.2 (7.14%) |
| Company Name | Anixa Biosciences Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.anixa.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
